Glyptara
Weekly GLP-1 formulation supporting metabolic health.
Advancing GLP-1 therapies through research.
Clinical innovation for obesity and diabetes care.
Focus areas
Science-led development for long-term outcomes.
GLP-1 innovation pipeline
Mountarico invests heavily in clinical research to unlock safer, longer-lasting GLP-1 therapies.
Adiprelle
Obesity-focused GLP-1 therapy built for sustained outcomes.
Vermida
Dual-pathway GLP-1 treatment with flexible dosing.
Rovista
Research-stage candidate optimized for long-term adherence.
GLP-1 Research
Research programs focused on metabolic health.
Clinical Trials
Rigorous studies to validate safety and efficacy.
Obesity Treatments
Therapies designed for sustained weight outcomes.
Diabetes Care
GLP-1 solutions for long-term glucose control.
Connect with Mountarico
Reach us at info@mountarico.com for proposals or partnerships.